First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Lesser, Glenn
Item TypeName
Academic Article A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306).
Academic Article Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.
Academic Article Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report.
Concept Antineoplastic Agents, Alkylating
Academic Article Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Academic Article An automated system for detecting nonadherence in laboratory testing and monitoring for myelosuppression in patients receiving self-administered oral chemotherapy.
Academic Article Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma.
Academic Article Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors.
Academic Article Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.
Academic Article Impact of temozolomide on gonadal function in patients with primary malignant brain tumors.
Academic Article Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.
Academic Article Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.
Academic Article A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Search Criteria
  • Alkylating Agents